QA: Immunome Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001472012_2025_Immunome_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations - Calc2': 2, '995200200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 7}}

Graph

Absolute values for 0001472012, Immunome Inc

  xvar xval
0 AssetsCurrent 221,339,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,113,000
3 remainder_Assets 8,789,000
4 LiabilitiesCurrent 54,307,000
5 LiabilitiesNoncurrent 4,769,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 99,356,391
9 ResearchAndDevelopmentExpense 226,572,548
10 remainder_Expenses 394,205,109
11 remainder_Revenues 10,352,412
12 remainder_NetIncome 63,358,381
13 remainder_ComprehensiveNetIncome 52,351
  yvar yval
0 Assets 240,241,000
1 Liabilities 59,076,000
2 Expenses 720,134,048
3 Revenues 10,352,412
4 StockholdersEquity 181,165,000
5 NetIncome -646,423,255
6 ComprehensiveNetIncome -646,397,080
7 BaseVar 546,607,096
8 EconomicCapitalRatiobeforeLimitedLiability -1.68
9 EconomicCapitalRatio 1.13

Edgar->Model Mapping

Feature Distribution

Change over Time